SEC 13F Intelligence

Artia Global Partners LP / TRVI

Artia Global Partners LP’s Trevi Therapeutics Inc Position

Does Artia Global Partners LP own Trevi Therapeutics Inc (TRVI)? Yes — 2.01M shares worth $24M (+4.81% of its 13F portfolio) as of Q1 2026.

Position Value
$24M
Q1 2026
Shares
2.01M
% of Portfolio
+4.81%
Quarters Held
4
currently held

Position History TRVI

Reported value by quarter
Q2 ’25: $7MQ2 ’25Q3 ’25: $18MQ3 ’25Q4 ’25: $25MQ4 ’25Q1 ’26: $24MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.01M$24M+4.81%
Q4 20252.01M$25M+3.57%
Q3 20252.00M$18M+2.90%
Q2 20251.31M$7M+1.73%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Artia Global Partners LP’s full portfolio or all institutional holders of TRVI.